STOCK TITAN

Report from Annual General Meeting of Vitrolife AB (publ)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Vitrolife's Annual General Meeting on April 28, 2021, confirmed a dividend of SEK 0.80 per share for 2020, with a record date set for April 30, 2021. The meeting re-elected board members, including Jón Sigurdsson as Chairman, and approved total remuneration for the board amounting to SEK 2,165,000. The board received authorization to issue up to 10,850,000 shares and to repurchase shares not exceeding 10% of the total shares. Remuneration principles for senior management were also approved, including a share-based incentive program.

Positive
  • Declared a dividend of SEK 0.80 per share, reflecting shareholder returns.
  • Board re-elections provide stability and continuity.
  • Authorization to issue shares could enable future capital raising.
  • Share buyback authorization may enhance shareholder value.
Negative
  • None.

GÖTEBORG, Sweden, April 28, 2021 /PRNewswire/ --

At Vitrolife's Annual General Meeting today, the following, amongst other things, was decided:                                                                                                 

  • The Board's proposed dividend of SEK 0.80 per share for the financial year 2020 was approved. Friday April 30, 2021 was adopted as the record day.
  • Re-election of Board members Henrik Blomquist, Lars Holmqvist, Pia Marions, Jón Sigurdsson and Karen Lykke Sorensen, in accordance with the election committee's proposal. Jón Sigurdsson was re-elected Chairman of the Board.
  • Remuneration to the members of the Board shall be totaling SEK 2,165,000, of which SEK 825,000 to the Chairman of the Board, SEK 275,000 to each of the other members of the Board, SEK 60,000 to the Chairman of the Audit Committee, SEK 60,000 to the Chairman of the Remuneration Committee and SEK 30,000 to the other members of these committees.
  • Authorization for the Board, for the time up until the next Annual General Meeting and on one or more occasions, to take a decision on the issue of a maximum of 10,850,000 shares in total, corresponding to just below 10 percent of the company's share capital.
  • The Board was authorized to take a decision, up until the next Annual General Meeting and on one or more occasions, with regard to the acquisition of the company's own shares. The Company can at no time hold more than 10 percent of the total shares in the Company.
  • The proposed principles for remuneration and other conditions of employment for the senior management were approved including the establishment of a share-based incentive program.
                     

Gothenburg, April 28, 2021
VITROLIFE AB (publ)
The Board

CONTACT:

Queries should be addressed to:
Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14

The information was submitted for publication, through the agency of the contact person set out above, at 5.00 pm CET on April 28, 2021.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/report-from-annual-general-meeting-of-vitrolife-ab--publ-,c3335566

The following files are available for download:

https://mb.cision.com/Main/1031/3335566/1409003.pdf

Report from Annual General Meeting

Cision View original content:http://www.prnewswire.com/news-releases/report-from-annual-general-meeting-of-vitrolife-ab-publ-301279282.html

SOURCE Vitrolife AB (publ)

FAQ

What was the dividend declared by Vitrolife at the Annual General Meeting 2021?

Vitrolife declared a dividend of SEK 0.80 per share for the financial year 2020.

When is the record date for the dividend declared by Vitrolife?

The record date for the dividend is April 30, 2021.

Who was re-elected as Chairman of the Board at Vitrolife's AGM?

Jón Sigurdsson was re-elected as Chairman of the Board.

What is the total remuneration for Vitrolife's board members?

The total remuneration for the board members is SEK 2,165,000.

How many shares is Vitrolife authorized to issue until the next AGM?

Vitrolife's board is authorized to issue up to 10,850,000 shares.

VITROLIFE AB UNSP/ADR

OTC:VTRLY

VTRLY Rankings

VTRLY Latest News

VTRLY Stock Data

2.71B
73.63M
Medical Devices
Healthcare
Link
United States of America
Gothenburg